세계의 의약품 등급 셀룰로오스 분말 시장 보고서(2025년)
Pharma Grade Cellulose Powder Global Market Report 2025
상품코드 : 1760687
리서치사 : The Business Research Company
발행일 : On Demand Report
페이지 정보 : 영문 175 Pages
 라이선스 & 가격 (부가세 별도)
US $ 4,490 ₩ 6,482,000
PDF (Single User License) help
PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 6,490 ₩ 9,370,000
PDF (Site License) help
PDF 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 8,490 ₩ 12,257,000
PDF (Enterprise License) help
PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.


ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.

한글목차

의약품 등급 셀룰로오스 분말 시장 규모는 향후 몇 년 동안 강력한 성장세를 보일 것으로 예상되며, 2029년까지 6.2%의 CAGR로 16억 2,000만 달러에 달할 것으로 예상됩니다. 예측 기간 동안 예상되는 성장은 맞춤형 의료의 부상, 지속가능한 부형제로의 전환, 생물학적 제제 및 바이오시밀러의 확대, 경구 약물전달 기술 혁신에 대한 관심 증가, 신흥 시장의 제약 인프라에 대한 투자 확대 등의 요인에 의해 이루어질 것으로 예상됩니다. 예측 기간 동안 주요 동향으로는 의약품 부형제 등급 재료에 대한 수요 증가, 방출 제어 약물전달 시스템 사용 증가, 식물 유래 및 재생 가능한 부형제로의 전환, 제어 약물전달 시스템 채택 증가, 순도 및 성능 향상을 위한 셀룰로오스 가공 기술 발전 등이 있습니다. 셀룰로오스 가공 기술의 발전 등을 들 수 있습니다.

헬스케어에 대한 수요 증가는 의약품 제조가 지속적으로 증가함에 따라 의약품 등급 셀룰로오스 분말 시장의 성장을 견인할 것으로 예상됩니다. 의약품 제조에는 안전성, 유효성, 규제 준수를 보장하기 위한 유효 성분 및 부형제의 배합, 합성, 품질 관리가 포함됩니다. 이 부문은 장기 투약이 필요한 만성질환의 확산으로 인해 확대되고 있습니다. 의약품 등급 셀룰로오스 분말은 신뢰할 수 있는 결합제, 충진제, 안정제 역할을 하며, 정제의 무결성과 안정적인 의약품 유통을 보장하여 의약품 제조를 지원하는 중요한 역할을 합니다. 예를 들어, 2023년 6월 유럽제약협회(EFPIA)는 유럽의 의약품 생산 총액이 4,228억 300만 달러(3,900억 유로)로 2022년 3,938억 5,700만 달러(3,633억 유로)에서 증가했다고 보고했습니다. 이러한 의약품 생산의 성장이 의약품 등급 셀룰로오스 분말 시장의 확대에 기여하고 있습니다.

의약품 등급 셀룰로오스 분말 시장의 주요 업체들은 미결정 셀룰로오스(MCC) 생산 시설의 확장에 주력하고 있습니다. 이러한 전용 시설에서는 정제된 셀룰로오스를 제어된 화학적 및 기계적 처리를 통해 가공하여 의약품용 미세 입자를 생산합니다. 예를 들어, 인도에 본사를 둔 부형제 제조업체인 Nichika Pharmaceuticals Specialties는 2023년 9월 인도 최대 규모의 미결정 셀룰로오스(MCC) 생산 공장을 나그푸르에 설립했습니다. 1,200톤의 생산능력을 갖춘 이 최신식 시설은 니틴 가드칼리(Nitin Gadkari) 연방 장관이 준공식을 가졌으며, 인도 정부의 부형제에 대한 생산 연동형 인센티브(PLI) 제도의 중요한 성과로 평가받고 있습니다. 이 공장은 니치카제약의 의약품 부형제의 세계 리더로서의 역할을 강화하여 국내 수요와 92개국 이상에 대한 수출을 지원하는 동시에 '메이크 인 인디아' 이니셔티브를 촉진하고 현지에 많은 고용 기회를 창출할 것입니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 동향과 전략

제4장 시장 - 금리, 인플레이션, 지정학, 무역 전쟁과 관세, 코로나와 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오

제5장 세계의 성장 분석과 전략 분석 프레임워크

제6장 시장 세분화

제7장 지역별·국가별 분석

제8장 아시아태평양 시장

제9장 중국 시장

제10장 인도 시장

제11장 일본 시장

제12장 호주 시장

제13장 인도네시아 시장

제14장 한국 시장

제15장 서유럽 시장

제16장 영국 시장

제17장 독일 시장

제18장 프랑스 시장

제19장 이탈리아 시장

제20장 스페인 시장

제21장 동유럽 시장

제22장 러시아 시장

제23장 북미 시장

제24장 미국 시장

제25장 캐나다 시장

제26장 남미 시장

제27장 브라질 시장

제28장 중동 시장

제29장 아프리카 시장

제30장 경쟁 구도와 기업 개요

제31장 기타 주요 기업과 혁신적 기업

제32장 세계의 시장 경쟁 벤치마킹과 대시보드

제33장 주요 인수합병

제34장 최근의 시장 동향

제35장 시장 잠재력이 높은 국가, 전략

제36장 부록

ksm
영문 목차

영문목차

Pharma-grade cellulose powder is a highly refined, plant-derived substance engineered to adhere to rigorous pharmaceutical quality criteria. It is frequently utilized as an excipient in drug formulations. Its properties of chemical inertness, non-toxicity, and stability ensure it is compatible with active pharmaceutical ingredients (APIs). Additionally, it improves the consistency and manufacturing efficiency of oral solid dosage forms.

The primary types of pharma-grade cellulose powder include microcrystalline cellulose (MCC), carboxymethyl cellulose (CMC), hydroxypropyl methylcellulose (HPMC), and hydroxypropyl cellulose (HPC). Microcrystalline cellulose (MCC) is a stable, compressible derivative of wood pulp that is widely used in the pharmaceutical industry as a binder, filler, and disintegrant due to its superior flow and direct compression characteristics. It serves multiple functions such as a binder, thickener, stabilizer, disintegrant, and coating agent, applicable in pharmaceuticals, nutraceuticals, cosmetics, and more. It is utilized by a variety of users, including contract research organizations (CROs), pharmaceutical and biotechnology firms, academic institutions, dietary supplement manufacturers, and the food and beverage sector.

The pharma grade cellulose powder market research report is one of a series of new reports from The Business Research Company that provides pharma grade cellulose powder market statistics, including the pharma grade cellulose powder industry global market size, regional shares, competitors with the pharma grade cellulose powder market share, detailed pharma grade cellulose powder market segments, market trends, opportunities, and any further data you may need to thrive in the pharma grade cellulose powder industry. This pharma grade cellulose powder market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The pharma-grade cellulose powder market size has grown strongly in recent years. It will grow from $1.19 billion in 2024 to $1.27 billion in 2025 at a compound annual growth rate (CAGR) of 6.5%. The growth observed in the historical period can be attributed to factors such as the rising demand for tablet binders, increased production of generic drugs, greater investment in pharmaceutical research and development, expansion in excipient manufacturing capacity, and regulatory approvals for cellulose-based excipients.

The pharma-grade cellulose powder market size is expected to see strong growth in the next few years. It will grow to $1.62 billion in 2029 at a compound annual growth rate (CAGR) of 6.2%. The anticipated growth during the forecast period is driven by factors such as the rise of personalized medicine, the shift toward sustainable excipients, the expansion of biologics and biosimilars, an increasing focus on innovations in oral drug delivery, and growing investments in pharmaceutical infrastructure in emerging markets. Key trends in the forecast period include a growing demand for excipient-grade materials in drug formulations, the increasing use of controlled-release drug delivery systems, a shift towards plant-based and renewable excipients, a rise in controlled drug delivery system adoption, and advancements in cellulose processing technologies to enhance purity and performance.

The increasing demand for healthcare is expected to drive the growth of the pharma-grade cellulose powder market, as pharmaceutical production continues to rise. Pharmaceutical manufacturing involves the formulation, synthesis, and quality control of active ingredients and excipients to ensure safety, effectiveness, and regulatory compliance. This sector is expanding due to the growing prevalence of chronic diseases that require long-term medication. Pharma-grade cellulose powder plays a crucial role in supporting pharmaceutical production by serving as a reliable binder, filler, and stabilizer, ensuring tablet integrity and consistent drug distribution. For example, in June 2023, the European Federation of Pharmaceutical Industries and Associations (EFPIA) reported that total pharmaceutical production in Europe reached $422,803 million (€390,000 million), an increase from $393,857 million (€363,300 million) in 2022. This growth in pharmaceutical production is contributing to the expansion of the pharma-grade cellulose powder market.

Leading companies in the pharma-grade cellulose powder market are focusing on expanding microcrystalline cellulose (MCC) production facilities. These dedicated facilities process purified cellulose through controlled chemical and mechanical treatments to create fine-grade particles for pharmaceutical use. For instance, in September 2023, Nitika Pharmaceuticals Specialties, an India-based excipient manufacturer, opened India's largest microcrystalline cellulose (MCC) manufacturing plant in Nagpur. This state-of-the-art facility, with an installed capacity of 1,200 metric tons, was inaugurated by Union Minister Nitin Gadkari and marks a key achievement under the Indian Government's Production Linked Incentive (PLI) scheme for excipients. This plant enhances Nitika Pharma's role as a global leader in pharmaceutical excipients, supporting both domestic demand and exports to over 92 countries, while also advancing the "Make in India" initiative and creating significant local employment opportunities.

In December 2024, Nordic Bioproducts Group, a Finland-based manufacturer of microcrystalline cellulose (MCC), formed a partnership with C.Q. Masso to enhance the supply of sustainable MCC for the beauty and personal care industries. This collaboration seeks to help manufacturers meet evolving EU regulations on harmful ingredients and product traceability by providing MCC as a renewable, wood-derived alternative to substances such as talc and titanium dioxide. The partnership supports the industry's move toward safer, more environmentally friendly formulations while ensuring a reliable and traceable supply chain across Europe. C.Q. Masso, based in Spain, specializes in manufacturing chemical products for various industries.

Major players in the pharma grade cellulose powder market are Roquette Freres, Ashland Global, JRS Pharma, Ankit Pulps & Boards Pvt. Ltd., DFE Pharma, Sigachi Industries Ltd., Accent Microcell Ltd., Maple Biotech Pvt. Ltd., Mingtai Chemical Co. Ltd., Patel Chem Specialties Limited, CelluTech, RanQ, Aromatic Cellulose Pvt. Ltd., Maruti Chemicals, Weifang Lude Chemical Co., Ltd., Patco Pharmaceuticals Pvt. Ltd., RK Dyechem Private Limited, Chemfield Cellulose, Vizag chemical, Tirumala inorganics

North America was the largest region in the pharma-grade cellulose powder market in 2024. The regions covered in pharma-grade cellulose powder report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the pharma-grade cellulose powder market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The pharma-grade cellulose powder market consists of sales of sodium carboxymethyl cellulose and cellulose acetate phthalate. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Pharma Grade Cellulose Powder Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on pharma grade cellulose powder market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for pharma grade cellulose powder ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The pharma grade cellulose powder market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

Scope

Table of Contents

1. Executive Summary

2. Pharma Grade Cellulose Powder Market Characteristics

3. Pharma Grade Cellulose Powder Market Trends And Strategies

4. Pharma Grade Cellulose Powder Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Pharma Grade Cellulose Powder Growth Analysis And Strategic Analysis Framework

6. Pharma Grade Cellulose Powder Market Segmentation

7. Pharma Grade Cellulose Powder Market Regional And Country Analysis

8. Asia-Pacific Pharma Grade Cellulose Powder Market

9. China Pharma Grade Cellulose Powder Market

10. India Pharma Grade Cellulose Powder Market

11. Japan Pharma Grade Cellulose Powder Market

12. Australia Pharma Grade Cellulose Powder Market

13. Indonesia Pharma Grade Cellulose Powder Market

14. South Korea Pharma Grade Cellulose Powder Market

15. Western Europe Pharma Grade Cellulose Powder Market

16. UK Pharma Grade Cellulose Powder Market

17. Germany Pharma Grade Cellulose Powder Market

18. France Pharma Grade Cellulose Powder Market

19. Italy Pharma Grade Cellulose Powder Market

20. Spain Pharma Grade Cellulose Powder Market

21. Eastern Europe Pharma Grade Cellulose Powder Market

22. Russia Pharma Grade Cellulose Powder Market

23. North America Pharma Grade Cellulose Powder Market

24. USA Pharma Grade Cellulose Powder Market

25. Canada Pharma Grade Cellulose Powder Market

26. South America Pharma Grade Cellulose Powder Market

27. Brazil Pharma Grade Cellulose Powder Market

28. Middle East Pharma Grade Cellulose Powder Market

29. Africa Pharma Grade Cellulose Powder Market

30. Pharma Grade Cellulose Powder Market Competitive Landscape And Company Profiles

31. Pharma Grade Cellulose Powder Market Other Major And Innovative Companies

32. Global Pharma Grade Cellulose Powder Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Pharma Grade Cellulose Powder Market

34. Recent Developments In The Pharma Grade Cellulose Powder Market

35. Pharma Grade Cellulose Powder Market High Potential Countries, Segments and Strategies

36. Appendix

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기